31 results
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
Bold & experienced leadership with expertise in CNS and rare disorders Pipeline with differentiated PK / PD and target engagement CNS programs
PRE 14A
LBPH
Longboard Pharmaceuticals, Inc.
28 Mar 24
Preliminary proxy
4:36pm
Independence of the Board of Directors
Board Leadership Structure
Role of the Board in Risk Oversight
Meetings of the Board of Directors
Information Regarding … and Nominating Committee believes that Ms. Lynch’s leadership and operational experience, as well as her extensive professional and educational experience
8-K
EX-99.2
dmj80dau1og7w2kwxg
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-99.1
2oj 54sqdt
29 Nov 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
dgeu5qzihe
2 Nov 23
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
7mxav
11 Oct 23
Regulation FD Disclosure
9:26am
DEF 14A
ibe 9sk4vk1599yrpo7
13 Apr 22
Definitive proxy
4:15pm
10-K
u0lst
3 Mar 22
Annual report
4:31pm
8-K
EX-99.1
6xssdhi1pud1p3n
10 Jan 22
Regulation FD Disclosure
7:01am